Loading people...
Claire Novorol is the Co-founder and Chief Medical Officer of Ada Health, based in London, United Kingdom. She previously worked as a pediatrician and clinical geneticist before earning a PhD in Developmental Neurobiology from the University of Cambridge and undergraduate medical degrees from the University of Bristol. At Ada Health, she oversees medical affairs for an AI-powered symptom assessment platform that has completed over 30 million evaluations and secured more than $190 million in venture funding, including a $119 million Series B led by Leaps by Bayer. Novorol also founded Doctorpreneurs in 2011, scaling the global network to tens of thousands of medical professionals, and recently expanded the company's strategic partnerships with pharmaceutical companies like Novartis. Her current focus centers on integrating artificial intelligence technologies into clinical care navigation and advancing digital health entrepreneurship.
Claire Novorol is an accomplished medical doctor, successful entrepreneur, and an oNetwork Expert Advisor at Saïd Business School, University of Oxford. She is best known as the co-founder of DrDoctor (now Lumeon), a leading digital health platform, and is a prominent figure in healthcare innovation.
As an oNetwork Expert Advisor, Claire Novorol primarily focuses on advising and supporting ventures rather than direct investment management. Her areas of expertise and interest for investment opportunities include digital health, health technology, artificial intelligence in healthcare, and broader healthcare innovation, particularly startups aiming to improve patient outcomes and healthcare efficiency.
Claire Novorol currently serves as an oNetwork Expert Advisor at Saïd Business School, University of Oxford. She leverages her extensive experience to mentor and guide entrepreneurs within the university's vibrant ecosystem, especially those in the health tech sector.
Claire Novorol stands out as a prominent figure in the healthcare innovation and entrepreneurship landscape, currently serving as an oNetwork Expert Advisor at Saïd Business School, University of Oxford. In this pivotal role, she contributes significantly to the university's vibrant entrepreneurial ecosystem, mentoring aspiring founders, connecting startups with essential resources, and fostering the growth of innovative ventures, particularly within the health technology sector.
Her career background is marked by a unique blend of medical expertise and entrepreneurial drive. Claire Novorol initially trained as a medical doctor, gaining invaluable firsthand experience within the National Health Service (NHS). This clinical foundation provided her with a profound understanding of the challenges and opportunities within healthcare delivery, which she later channeled into entrepreneurial endeavors. She is widely recognized as the co-founder of DrDoctor, a pioneering digital health platform that has since evolved into Lumeon. DrDoctor revolutionized patient engagement and operational efficiency within healthcare systems, demonstrating Claire's ability to identify critical needs and develop scalable technological solutions.
Through her work with DrDoctor and her advisory roles, Claire Novorol's investment focus areas are clearly defined. She is deeply committed to supporting and advancing ventures in digital health, health technology, artificial intelligence in healthcare, and broader healthcare innovation. Her insights are particularly valuable for startups developing solutions for patient communication, operational streamlining, data analytics, and personalized medicine. While her primary role as an Expert Advisor involves guidance and mentorship rather than direct fund management, her extensive experience as a successful founder and her deep understanding of the healthcare market make her an invaluable resource for both entrepreneurs seeking to build impactful companies and investors looking for promising opportunities in the health tech space.
Claire's academic background, including an MBA from Saïd Business School, University of Oxford, further enhances her strategic acumen and business leadership capabilities. This combination of medical knowledge, entrepreneurial success, and business education positions her as a thought leader capable of bridging the gap between clinical needs and technological solutions. Her contributions to the Oxford entrepreneurial network help shape the next generation of healthcare innovators, making her a key influencer in the future of digital health.
